Khalaf-Allah Abd El-Rahman M, El-Gengaihi Souad E, Hamed Manal A, Zahran Hanan G, Mohammed Mona A
a Food Science and Technology Department, Faculty of Agriculture , Cairo University , Cairo , Egypt.
b Medicinal & Aromatic Plants Department , National Research Center , Cairo , Egypt.
J Diet Suppl. 2016;13(4):378-92. doi: 10.3109/19390211.2015.1099584. Epub 2015 Dec 3.
The role of Physalis peruviana (golden berry) as functional food against hepato-renal fibrosis induced by carbon tetrachloride (CCl4) was evaluated. The chemical composition of leaves referred the presence of withanolides and flavonoids. Two compounds, ursolic acid and lupeol, were isolated and their structures were elucidated by different spectral analysis techniques. The biological evaluation was conducted on different animal groups; control rats, control orally treated with plant extract (500 mg/kg body weight twice a week for six consecutive weeks), CCl4 (0.5 ml/kg body weight diluted to 1:9 (v/v) in olive oil and injected intraperitoneally) group, CCl4 treated with plant extract and CCl4 treated with silymarin as a reference herbal drug. The evaluation was done through measuring oxidative stress markers; malondialdehyde (MDA), superoxide dismutase (SOD) and nitric oxide (NO). Liver function indices; aspartate and alanine aminotransferases (AST & ALT), alkaline phosphatase (ALP), gamma glutamyl transferase (GGT), bilirubin and total hepatic protein were also estimated. Kidney disorder biomarkers; creatinine, urea and serum protein were also evaluated. The results revealed plant safety and decrease in NO, MDA, IgG, ALP, tissue protein, bilirubin, creatinine and urea levels. Increase in SOD, AST, ALT, GGT and serum protein levels were observed. Improvement in liver and kidney histopathological architectures were also seen. In conclusion, Physalis peruviana recorded a significant protective role in liver and kidney against fibrosis. Further studies are needed to evaluate its isolated compounds and its use in pharmacological applications and clinical uses.
评估了灯笼果(酸浆)作为功能性食品对四氯化碳(CCl4)诱导的肝肾纤维化的作用。叶片的化学成分显示含有睡茄内酯和黄酮类化合物。分离出两种化合物,熊果酸和羽扇豆醇,并通过不同的光谱分析技术阐明了它们的结构。对不同动物组进行了生物学评估;对照组大鼠、口服植物提取物的对照组(500 mg/kg体重,每周两次,连续六周)、CCl4组(0.5 ml/kg体重,在橄榄油中稀释至1:9(v/v),腹腔注射)、用植物提取物处理的CCl4组以及用作为参考草药的水飞蓟宾处理的CCl4组。通过测量氧化应激标志物进行评估;丙二醛(MDA)、超氧化物歧化酶(SOD)和一氧化氮(NO)。还测定了肝功能指标;天冬氨酸和丙氨酸转氨酶(AST和ALT)、碱性磷酸酶(ALP)、γ-谷氨酰转移酶(GGT)、胆红素和总肝蛋白。还评估了肾脏疾病生物标志物;肌酐、尿素和血清蛋白。结果显示植物具有安全性,且NO、MDA、IgG、ALP、组织蛋白、胆红素、肌酐和尿素水平降低。观察到SOD、AST、ALT、GGT和血清蛋白水平升高。肝脏和肾脏的组织病理学结构也有所改善。总之,灯笼果在肝脏和肾脏抗纤维化方面发挥了显著的保护作用。需要进一步研究来评估其分离出的化合物及其在药理学应用和临床用途中的使用情况。